The partnership sounds like a win-win—so long as 23andMe's client data stays anonymous.
23andMe, the Mountain View, California-based company that offers a $99 consumer DNA kit, announced an agreement with Pfizer, one of the world's largest pharmaceutical companies and producer of drugs like Lipitor, Zoloft, and Viagra. As part of the deal, Pfizer will get access to 23andMe's database of genetic information gathered through its DNA kits. 23andMe has genotyped more than 800,000 people, 80% of whom have consented to allow their genetic information to be used for research.
No comments:
Post a Comment